The largest database of trusted experimental protocols

30 protocols using fluostar optima spectrophotometer

1

Intracellular Calcium Imaging Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were incubated with uo-4-AM (Thermo sher, USA) at 37 ºC in buffer containing 137 mM NaCl, 4 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 glucose, 10 HEPES-NaOH (pH 7,4) for varying times and concentrations as speci ed in Results. Fluorescence recordings were carried out in triplicate wells in a Fluostar Optima spectrophotometer (BMG Labtechnologies, Germany). Excitation wavelength lter was a bandpass 480/10 nm, emitted uorescence was recovered through a 520/10 lter. Fluorescence was blanksubtracted and expressed as a percentage of intracellular or of total overall F4 uorescence as follows:
1) % of intracellular uorescence obtained by cell lysis:
2)% of total overall uorescence resulting from the addition of intracellular and extracellular uorescence recorded from the loading buffer.
In some experiments intracellular F4 concentrations were interpolated by plugging blank-subtracted uorescence values in the equation of a [F4]-uorescence intensity calibration line, obtained measuring uorescence of known concentrations of a potassium salt of F4 readily soluble in aqueous buffer (Fig. 4.inset).
+ Open protocol
+ Expand
2

Evaluating Topotecan's Cytotoxic Activity in Neuroblastoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytotoxic activity of topotecan (Hycamtin) against SK‐N‐SH, IMR‐32 and LAN‐1 neuroblastoma cell lines was measured by assessing changes in cell viability as determined by the PrestoBlue® Cell Viability Reagent (ThermoFisher Scientific, Burlington, ON, Canada). The concentration of drug that decreased the viability of cells by 50% defined the IC50 of the drug. To evaluate the effect of exposure time, SK‐N‐SH, IMR‐32 and LAN‐1 neuroblastoma cell lines were incubated with increasing concentrations of the drug for 1, 4, 8, 24, 48, or 72 h. Following each time point, the drug containing medium was removed and replaced with 200 μL of fresh medium and the cells were incubated such that all cells were maintained in culture for a total of 72 h. The cell viability was then determined by measuring fluorescence (excitation at 544 nm and emission at 590 nm) with a FLUOstar OPTIMA Spectrophotometer (BMG Labtechnologies).
+ Open protocol
+ Expand
3

Microplate Antioxidant Reducing Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antioxidant reducing activity was determined with the Folin-Ciocalteu (F-C) method in a microplate format as described by Serem and Bester. 23 To a 96-well plate, 10 μL of a 10% (v/v) tea solution of each sample was added to each well. This was followed by 50 μL of a 1:15 F-C reagent solution and 50 μL of a 7.5% (w/v) Na 2 CO 3 solution. The samples were mixed and the absorption determined at 630 nm using a FLUOstar OPTIMA spectrophotometer (BMG labtechnologies, Offenburg, Germany). A 1 mg/mL gallic acid solution was diluted to 0 -0.4 mg/mL to prepare a standard curve and calculate antioxidant reducing activity, expressed as mg gallic acid equivalents (GAE)/g DM tea.
+ Open protocol
+ Expand
4

Antioxidant Capacity Measurement by ORAC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Procedures used were based on a modified method by Ou et al. 24 A concentration series of 0 -0.8 mM was made from 1 mM Trolox. A 1% (v/v) tea extract in water, or 10 µL Trolox standard, was added to each well of a Greiner Bio-one 96-well opaque plate. A 200 µL volume of experimental solution was added, and samples were mixed well. The final assay contained 0.04 mM Trolox or 0.05% tea, 101.33 nM fluorescein disodium and 0.02 M AAPH in 0.137 M PBS. The microplate was placed into the plate reader and incubated at 37 0 C. Fluorescence was measured at five minute intervals for four hours using a FLUOstar OPTIMA spectrophotometer (BMG Labtechnologies, Offenburg, Germany). The assay protocol was as follows: 0.0s measurement start time, 10 flashes per cycle, 300 seconds cycle time, 485 nm for the excitation filter and 520 nm for the emission filter. The final sample ORAC values were calculated with a net area under the decay curves (AUC). The following equation was used:
+ Open protocol
+ Expand
5

SGLT2 Inhibitors Impact on HUVEC Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs (2 × 104 cells/well) were allowed to attach to 96-well plates for 4 h in MV2 medium containing 5% (v/v) MV2 Supplement Mix and subsequently incubated in the same medium with DMSO (vehicle) or SGLT2 inhibitors for 24 h. CellTiter 96® AQueous One Solution Aqueous Cell solution was added 1.5 h prior to the end of incubation, at which point A485 was measured on a BMG Labtech FLUOstar Optima spectrophotometer microplate reader.
+ Open protocol
+ Expand
6

Extracellular Enzyme Potential Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microbial extracellular enzyme potential activity (hereafter enzyme activity) was measured in each microcosm at the end of the incubation. Eight enzymes were measured from a 91-mL subsample of each microcosm following a protocol developed by Bell et al. (2013) , modified to handle water. The following enzymes were targeted with fluorescently labeled substrates to capture potential N, P, C, and S degradation activity:
alkaline phosphatase (PHOS), and b-D-xylosidase (XYL). After 3 h at room temperature, the centrifuged supernatant for each sample was read (340/460 nm) on a FLUOstar Optima spectrophotometer (BMG Labtech, Cary, North Carolina, USA) in black optical plates.
+ Open protocol
+ Expand
7

SGLT2 Inhibitor Effects on HUVEC Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs (2 × 104 cells/well) were allowed to attach to 96-well plates for 4 h in MV2 medium containing 2.5% or 5% (v/v) MV2 Supplement Mix (Promocell C-39226) containing serum and growth factors and subsequently incubated in the same medium with DMSO (vehicle) or SGLT2 inhibitors for 12 h. BrdU reagent was then added and cells further incubated for 24 h. BrdU incorporation was assessed by measuring A485/520 on a BMG Labtech FLUOstar Optima spectrophotometer microplate reader.
+ Open protocol
+ Expand
8

Evaluating Grape Seed Oil Antioxidant Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Group III with the ratio of 40:60% with an emulsifier (5%) and group IV with the ratio of 40:60% with 2.5% emulsifier was evaluated for the monitoring of stability in a room (24 °C ± 1) and fridge (2 °C ± 1) temperatures.
The 1, 1-diphenyl-2-picrylhydrazyl radical (DPPH) is a stable radical with a maximum absorbance at 517 nm that can readily undergo reduction by an antioxidant. The scavenging effect on DPPH radical was determined by the method reported earlier with minor modifications [13 (link)]. Different concentrations of grape seed oil in methanol (20 μl) were mixed with 270 μl of 0.004% methanolic solution of DPPH. The mixture was shaken vigorously and left to stand for 30 min in dark at 30 °C, and the absorbance was then measured at 517 nm with a FLUostar OPTIMA spectrophotometer (BMG Labtech, Germany).
+ Open protocol
+ Expand
9

Cytotoxicity Assessment via LDH Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cytotoxicity assay, 100 µl of cell suspension was seeded into a 96-well plate (2 × 104 cells/well) and allowed to adhere overnight. On the following day, the cells were incubated with BAs then 100 µl supernatant from each of the wells was carefully transferred into a new 96-well plate containing 100 µl reaction mixture. We then measured lactate dehydrogenase (LDH) activity at 490 nm using a FLUOstar OPTIMA Spectrophotometer (BMG Labtech, Ortenberg, Germany). For background controls, we measured 200 µl assay medium, without cells. For low controls, we used 100 µl cell suspension and 100 µl assay medium. In the case of high controls, the mixture of 100 µl cell suspension and 100 µl Triton-X 100 (0.1%) solution was measured. The LDH release induced by Triton-X 100 was assigned to 100%. The average absorbance values of each of the triplicates were calculated and the average value of the background control (LDH activity contained in the assay medium) was subtracted from each of the samples to reduce background noises. We then calculated the percentage of cytotoxicity using the following formula: Cytotoxicity (%) = (exp. value–low control/high control-low control)*100. Low control determines the LDH activity released from the untreated normal cells (spontaneous LDH release), whereas high control determines the maximum releasable LDH activity in the cells (maximum LDH release).
+ Open protocol
+ Expand
10

Galunisertib Cytotoxicity in Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
HDFs were cultured in 96-well plates in Dulbecco’s Modified Eagle Medium (DMEM) supplemented in 10% fetal bovine serum (FBS) in a 5% CO2 humidified environment until 60–75% confluent. Serial dilutions of galunisertib (0 µM, 0.01 µM, 0.1 µM, 1 µM, 2.5 µM, 10 µM, and 100 µM), together with a 1% DMSO and 5% DMSO control, were added to the FPDF and HDF cell cultures. FPDFs were incubated with galunisertib for 0, 24, 72, and 168 h without medium exchange. After incubation, 10 µL of MTT reagent (ATCC 30-1010K kit) was added to each well with a 2 h incubation time. A proprietary detergent reagent (100 µL) was added, and cells were allowed to incubate for 2 h at room temperature. The absorbance at 570 nm was then measured using a BMG LabTech Fluostar Optima spectrophotometer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!